New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Harpoon Therapeutics, Inc.
HARP
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

865M

Biotechnology

23.01USD
Shape0.02 ( 0.09%)
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

467%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

1%

Quote Panel

Shape
Updated November 13, 2024
1W % 1M % 3M % 1Y 164.79 %

Key Metrics

Shape
  • Market Cap

    865.08M


  • Shares Outstanding

    37.60M


  • Share in Float

    25.56M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    23.01


  • Average Volume

    1.13M


  • Beta

    1.547796


  • Range

    3.11-23.21


  • Industry

    Biotechnology


  • Website

    https://www.harpoontx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

23.17x

P/S Ratio

20.01x

P/B Ratio

3.2

Debt/Equity

-82.7%

Net Margin

$-1.5

EPS

How HARP compares to sector?

P/E Ratio

Relative Strength

Shape

HARP

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$19M

Shape-66%

2025-Revenue

$2.79

Shape39%

2025-EPS

$17M

Shape66%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Goldman Sachs

initialise

Previous: Not converted

2022-12-14

Now: Sell

Cowen & Co.

initialise

Previous: Not converted

2022-12-14

Now: Hold

Wedbush

upgrade

Previous: Not converted

2022-05-16

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

N/A

-6.60
vs -4.50

Q1.22

arrow
arrow

N/A

-6.20
vs -3.70

Q2.22

arrow
arrow

N/A

-5.30
vs -5.20

Q3.22

arrow
arrow

N/A

-3.50
vs -5.10

Q4.22

arrow
arrow

N/A

-5.50
vs -6.60

Q1.23

arrow
arrow

N/A

-3.10
vs -6.20

Q2.23

arrow
arrow

+106%

0.3
vs -5.30

Q3.23

arrow
arrow

N/A

-0.46
vs -3.50

Q4.23

arrow
arrow

N/A

-0.52
vs -5.50

Q1.24

arrow
arrow

N/A

-0.35
vs -3.10

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

-42%

4.3M  vs 7.5M

Q1.22

arrow
arrow

-34%

5.9M  vs 9M

Q2.22

arrow
arrow

+42%

8.3M  vs 5.8M

Q3.22

arrow
arrow

+204%

13.6M  vs 4.5M

Q4.22

arrow
arrow

-5%

4.1M  vs 4.3M

Q1.23

arrow
arrow

+45%

8.6M  vs 5.9M

Q2.23

arrow
arrow

+144%

20.2M  vs 8.3M

Q3.23

arrow
arrow

-67%

4.4M  vs 13.6M

Q4.23

arrow
arrow

+218%

13M  vs 4.1M

Q1.24

arrow
arrow

-27%

6.3M  vs 8.6M

Return on EquityShape

status-upQoQ

Q4.21

arrow
arrow

-37%

-0.37
vs -0.22

Q1.22

arrow
arrow

-49%

-0.49
vs -0.37

Q2.22

arrow
arrow

-65%

-0.65
vs -0.49

Q3.22

arrow
arrow

-67%

-0.67
vs -0.65

Q4.22

arrow
arrow

-335%

-3.35
vs -0.67

Q1.23

arrow
arrow

-1685%

-16.85
vs -3.35

Q2.23

arrow
arrow

+35%

0.35
vs -16.85

Q3.23

arrow
arrow

-40%

-0.40
vs 0.35

Institutionnal OwnershipShape

status-upQoQ

Q1.22

arrow
arrow

79

79
vs 85

-7%

Q2.22

arrow
arrow

56

56
vs 79

-29%

Q3.22

arrow
arrow

45

45
vs 56

-20%

Q4.22

arrow
arrow

49

49
vs 45

9%

Q1.23

arrow
arrow

46

46
vs 49

-6%

Q2.23

arrow
arrow

45

45
vs 46

-2%

Q3.23

arrow
arrow

2

2
vs 45

-96%

Q4.23

arrow
arrow

1

1
vs 2

-50%

Earnings Growth

Latest News